IL6 and breast cancer: Increased levels of IL-6 promote HER2 expression through the activation of STAT3, indicating that the TNFR2/NF-κB/IL-6/JAK/STAT3/HER2 signaling pathway may play a significant role in the progression and the establishment of EMT, producing a highly aggressive form of BC [73].